Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Ortho-McNeil scientists prepare and test novel PDE5 inhibitors

June 12, 2003

New PDE5 inhibitors in Schering-Plough development pipeline

June 11, 2003

Intranasal apomorphine enters new phase II study in erectile dysfunction

June 6, 2003

Influence of sildenafil on duodenal function and cirrhotic portal hemodynamics

June 4, 2003

Topiglan enters new phase II study for erectile dysfunction

June 4, 2003

No evidence of carcinogenicity in NexACT rat study

June 2, 2003

Phase II efficacy data reported for intranasal apomorphine in FSD

June 2, 2003

Oxytrol submission accepted for review in Canada

May 28, 2003

Solifenacin succinate safe and effective in patients with overactive bladder

May 26, 2003

Favorable effects on bone disease reported for lanthanum carbonate in hemodialysis

May 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...